Does endotoxin contribute to aseptic loosening of orthopedic implants?

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 72, Issue 1, 2005, Pages 179-185

  Greenfield, Edward M ^a,b   Bi, Yanming ^a,b,c   Ragab, Ashraf A ^a,d   Goldberg, Victor M ^a   Nalepka, Jennifer L ^a   Seabold, Joscelyn M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Aseptic loosening; Endotoxin; Lipopolysaccharide; Osteoclast; Osteolysis

Indexed keywords

BIOLOGICAL ACTIVITY; ENDOTOXIN; ORTHOPEDIC IMPLANTS; OSTEOLYSIS;

ANTIBIOTICS; BACTERIA; BIOFILMS; BONE CEMENT; IMPLANTS (SURGICAL); PATIENT TREATMENT; PROTEINS; TITANIUM;

ORTHOPEDICS;

ANTIINFECTIVE AGENT; BONE CEMENT; ENDOTOXIN; HYDROXYAPATITE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; POLY(METHYL METHACRYLATE); POLYETHYLENE; TITANIUM; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

BIOFILM; BIOLOGICAL ACTIVITY; BONE REGENERATION; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; HUMAN; HYPOTHESIS; IMPLANT; INTERMETHOD COMPARISON; NONHUMAN; ORTHOPEDICS; OSTEOCLAST; OSTEOLYSIS; PROSTHESIS LOOSENING; REVIEW; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; ENDOTOXINS; HUMANS; ORTHOPEDIC EQUIPMENT; PROSTHESES AND IMPLANTS; WATER;

EID: 11144336076     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30150     Document Type: Review

References (82)

1. Wright TM, Goodman SB, editors. Implant wear in total joint replacement. Rosemount, IL: American Academy of Orthopaedic Surgeons; 2001.
2. Ingram J, Stone M, Fisher J, Ingham E. The influence of molecular weight, crosslinking and counterface roughness on TNF-alpha production by macrophages in response to ultra high molecular weight polyethylene particles. Biomaterials 2004;25:3511-3522.
3. Baker D, Bellare A, Pruitt L. The effects of degree of crosslinking on the fatigue crack initiation and propagation resistance of orthopedic-grade polyethylene. J Biomed Mater Res 2003;66A:146-154.
4. Bradford L, Baker D, Graham J, Chawan A, Ries M, Pruitt L. Wear and surface cracking in early retrieved highly cross-linked polyethylene acetabular liners. J Bone Joint Surg 2004;86A:1271-1282.
5. Hauschildt S, Brabetz W, Schromm AB, Hamann L, Zabel P, Rietschel ET, Muller-Loennies S. Structure and activity of endotoxins. In: Aktories K, Just I, editors. Handbook of experimental pharmacology. Berlin: Springer; 2000. p 619-659.
6. Wang ZM, Liu C, Dziarski R. Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J Biol Chem 2000;275:20260-20267.
7. Bi Y, Van De Motter RR, Ragab AA, Goldberg VM, Anderson JM, Greenfield EM. Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts. J Bone Joint Surg 2001;83A:501-508.
8. Greenfield EM, Bi Y, Ragab AA, Goldberg VM, Van De Motter RR. The role of osteoclast differentiation in aseptic loosening. J Orthop Res 2002;20:1-8.
9. Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 1999;154:203-210.
10. Schwarz EM, Benz EB, Lu AP, Goater JJ, Mollano AV, Rosier RN, Puzas JE, O'keefe RJ. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 2000;18:849-855.
11. Kaar SG, Ragab AA, Kaye SJ, Kilic BA, Jinno T, Goldberg VM, Bi Y, Stewart MC, Carter JR, Greenfield EM. Rapid repair of titanium particle-induced osteolysis is dramatically reduced in aged mice. J Orthop Res 2001;19:171-178.
12. Kadoya Y, Revell PA, Al-Saffer N, Kobayashi A, Scott G, Freeman MAR. Bone formation and bone resorption in failed total joint arthroplasties: histomorphometric analysis with histochemical and immunohistochemical technique. J Orthop Res 1996;14:473-482.
13. Bi Y, Seabold JM, Kaar SC, Ragab AA, Goldberg VM, Anderson JM, Greenfield EM. Adherent endotoxin on orthopaedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 2001;16:2082-2091.
14. Lowe R, Nalepka J, Van De Motter R, Goldberg V, Bi Y, Greenfield E. Stimulation of osteoclast differentiation by wear debris depends on synergistic interactions between IL-1a, IL-1b, IL-6, and TNFa. Trans Orthop Res Soc 2001;26:959.
15. Ragab AA, Nalepka JL, Bi Y, Greenfield EM. Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am J Physiol Cell Physiol 2002;283:C679-C687.
16. Quinn J, Joyner C, Triffitt JT, Athanasou NA. Polymethyl-methacrylate- induced inflammatory macrophages resorb bone. J Bone Joint Surg 1992;74B:652-658.
17. Pandey R, Quinn J, Joyner C, Murray DW, Triffitt JT, Athanasou NA. Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells. Ann Rheum Dis 1996;55:388-395.
18. Sabokbar A, Fujikawa Y, Neale S, Murray DW, Athanasou NA. Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 1997;56:414-420.
19. Wang M, Nesti L, Tuli R, Lazatin J, Danielson K, Sharkey P, Tuan R. Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 2002;20:1175-1184.
20. Allen MJ, Myer BJ, Millett PJ, Rushton N. The effects of particulate cobalt, chromium and cobalt-chromium alloy on human osteoblast-like cells in vitro. J Bone Joint Surg 1997; 79B:475-482.
21. Yao J, Cs-Szabo G, Jacobs JJ, Kuettner KE, Glant TT. Suppression of osteoblast function by titanium particles. J Bone Joint Surg 1997;79A:107-112.
22. Dean DD, Schwartz Z, Liu Y, Blanchard CR, Agrawal CM, Mabrey JD, Sylvia VL, Lohmann CH, Boyan BD. The effect of ultra-high molecular weight polyethylene wear debris on MG63 osteosarcoma cells in vitro. J Bone Joint Surg 1999;81A:452-461.
23. Goodman S, Aspenberg P, Song Y, Knoblich G, Huie P, Regula D, Lidgren L. Tissue ingrowth and differentiation in the bone-harvest chamber in the presence of cobalt-chromium-alloy and high-density-polyethylene particles. J Bone Joint Surg 1995; 77A:1025-1035.
24. Goodman S, Song Y, Chun L, Regula D, Aspenberg P. Effects of TGFbeta on bone ingrowth in the presence of polyethylene particles. J Bone Joint Surg 1999;81B:1069-1075.
25. Goodman S, Song Y, Yoo J, Fox N, Trindade M, Kajiyama G, Ma T, Regula D, Brown J, Smith R. Local infusion of FGF-2 enhances bone ingrowth in rabbit chambers in the presence of polyethylene particles. J Biomed Mater Res 2003;65A:454-461.
26. Ragab AA, Van DeMotter RR, Lavish SA, Goldberg VM, Ninomiya JT, Carlin CR, Greenfield EM. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 1999;17:803-809.
27. Taki N, Seabold JM, Nalepka JL, Togawa D, Goldberg VM, Rimnac CM, Greenfield EM. Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res. Forthcoming.
28. Ragab AA, Lavish SA, Van De Motter RR, Goldberg VM, Greenfield EM. Stimulation of cytokine production by titanium wear particles is due to adherent endotoxin. Trans Orthop Res Soc 1998;23:355.
29. Bi Y, Collier TO, Goldberg VM, Anderson JM, Greenfield EM. Adherent endotoxin mediates biological responses of titanium particles without stimulating their phagocytosis. J Orthop Res 2002;20:696-703.
30. Seabold JM, Nalepka JL, Stewart MC, Greenfield EM. Systemic endotoxin and titanium-induced osteolysis. Trans Orthop Res Soc 2003;28:285.
31. Seabold JM, Taki N, Goldberg VM, Greenfield EM. Endotoxin accumulation during polyethylene (PE) induced osteolysis in murine calvaria. Trans Orthop Res Soc 2004;29:1515.
32. Sun DH, Trindade MC, Nakashima Y, Maloney WJ, Goodman SB, Schurman DJ, Smith RL. Human serum opsonization of orthopedic biomaterial particles: protein-binding and monocyte/ macrophage activation in vitro. J Biomed Mater Res 2003;65A:290-298.
33. Wright SD. Toll, a new piece in the puzzle of innate immunity. J Exp Med 1999;189:605-609.
34. Majde JA. Endotoxin detection. Immunol Today 1992;13:328-329.
35. Morrison DC, Curry BJ. The use of polymyxin B and C3H/HeJ mouse spleen cells as criteria for endotoxin contamination. J Immunol Methods 1979;27:83-92.
36. Seabold J, Johnstone B, Stewart M, Greenfield E. Toll-like receptor 4 mediates osteolysis induced by titanium particles in mice. Trans Orthop Res Soc 2002;27:1061.
37. Clohisy JC, Teitelbaum S, Chen S, Erdmann JM, Abu-Amer Y. Tumor necrosis factor-a mediates polymethylmethacrylate particle-induced NF-kB activation in osteoclast precursor cells. J Orthop Res 2002;20:174-181.
38. Wright SD, Tobias PS, Ulevitch RJ, Ramos RA. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 1989;170:1231-1241.
39. Troelstra A, Graaf-Miltenbury LM, Bommel T, Verhoef J, Kesell KMV, Strijp JGV. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18. J Immunol 1999;162:4220-4225.
40. Hitchins VM, Merritt K. Decontaminating particles exposed to bacterial endotoxin (LPS). J Biomed Mater Res 1999;46:434-437.
41. Akisue T, Bauer TW, Farver CF, Mochida Y. The effect of particle wear debris on NFkappaB activation and pro-inflammatory cytokine release in differentiated THP-1 cells. J Biomed Mater Res 2002;259:507-515.
42. Lee DH, Park JC, Suh H. Synergistic induction of cyclooxygenase-II by bacterial lipopolysaccharide in combination with particles of medical device materials in a murine macrophage cell line J774A.1. J Biomed Mater Res 2001;55:547-553.
43. Charlebois S, Daniels A, Smith R. Metabolic heat production as a measure of macrophage response to particles from orthopedic implant materials. J Biomed Mater Res 2002;59:166-175.
44. Cho DR, Shanbhag AS, Hong CY, Baran GR, Goldring SR. The role of adsorbed endotoxin in particle-induced stimulation of cytokine release. J Orthop Res 2002;20:704-713.
45. Daniels AU, Barnes FH, Charlebois SJ, Smith RA. Macrophage cytokine response to particles and lipopolysaccharide in vitro. J Biomed Mater Res 2000;49:469-478.
46. Brooks RA, Wimhurst JA, Rushton N. Endotoxin contamination of particles produces misleading inflammatory cytokine responses from macrophages in vitro. J Bone Joint Surg 2002; 84B:295-299.
47. Carmody E, Schwarz E, O'Keefe RA. vIL-10 inhibits wear debris-induced cytokine production, osteoclastogenesis and bone resorption. Trans Orthop Res Soc 2002;27:5.
48. Skoglund B, Larsson L, Aspenberg PA. Bone-resorptive effects of endotoxin-contaminated high-density polyethylene particles spontaneously eliminated in vivo. J Bone Joint Surg 2002;84B:767-773.
49. Aspenberg P, Herbertsson P. Periprosthetic bone resorption. Particles versus movement. J Bone Joint Surg 1996;78B:641-646.
50. Bechtold JE, Kubic V, Soballe K. Bone ingrowth in the presence of particulate polyethylene. Synergy between interface motion and particulate polyethylene in periprosthetic tissue response. J Bone Joint Surg 2002;84B:915-919.
51. Matthews JB, Mitchell W, Stone M, Fisher J, Ingham E. A novel three-dimensional tissue equivalent model to study the combined effects of cyclic mechanical strain and wear particles on the osteolytic potential of primary human macrophages in vitro. Proc Inst Mech Eng [H] 2001;215:479-486.
52. McEvoy A, Jeyam M, Ferrier G, Evans CE, Andrew JG. Synergistic effect of particles and cyclic pressure on cytokine production in human monocyte/macrophages: proposed role in periprosthetic osteolysis. Bone 2002;30:171-177.
53. Skoglund B, Aspenberg P. PMMA particles and pressure: a study of the osteolytic properties of two agents proposed to cause prosthetic loosening. J Orthop Res 2003;21:196-201.
54. Freeman M, Plante-Bordeneuve P. Early migration and late aseptic failure of proximal femoral prostheses. J Bone Joint Surg 1994;76B:432-438.
55. Karrholm J, Borssen B, Lowenhielm G, Snorrason F. Does early micromotion of femoral stem prostheses matter? 4-7-year stereoradiographic follow-up of 84 cemented prostheses. J Bone Joint Surg 1994;76B:912-917.
56. Ryd L, Albrektsson B, Carlsson L, Dansgard F, Herberts P, Lindstrand A, Regner L, Toksvig-Larsen S. Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses. J Bone Joint Surg 1995;77B:377-383.
57. Stocks G, Freeman M, Evans S. Acetabular cup migration. Prediction of aseptic loosening. J Bone Joint Surg 1995;77B:853-861.
58. Mjoberg B. Theories of wear and loosening in hip prostheses. Wear-induced loosening vs loosening-induced wear: a review. Acta Orthop Scand 1994;65:361-371.
59. Schmalzried T, Jasty M, Harris W. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg 1992;74A:849-863.
60. Wilkinson JM, Hamer AJ, Stockley I, Eastell R. Implant wear and osteolysis: wear threshold versus continuous gradient of risk. Trans Orthop Res Soc 2004;29:1516.
61. Nalepka JL, Dennis JE, Greenfield EM. Adherent endotoxin on titanium alloy substrates inhibits growth and osteoblastic differentiation of mesenchymal precursor cells. Trans Orthop Res Soc 2003;28:1373.
62. Campbell P, Mirra J, Catelas I. Histopathology of tissues from Inter-Op acetabular sockets. Trans Orthop Res Soc 2002;27:187.
63. Bloebaum RD, Whitaker EL, Szakacs J, Hofman A. The tissue response to an injection of gamma sterilized mineral oil in rabbits. Trans Orthop Res Soc 2003;28:1345.
64. Cooperstock MS, Tucker RP, Baublis JV. Possible pathogenic role of endotoxin in Reye's syndrome. Lancet 1975;1:1272-1274.
65. Inada K, Endo S, Takahashi K, Suzuki M, Narita T, Yoshida T, Suda H, Komuro T, Yoshida M. Establishment of a new perchloric acid treatment method to allow determination of the total endotoxin content in human plasma by the limulus test and clinical application. Microbiol Immunol 1991;35:303-314.
66. Charnley J. Low friction arthroplasty of the hip. Berlin: Springer-Verlag; 1979.
67. Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg 1985;67A:264-273.
68. Mariani BD, Martin DS, Levine MJ, Booth RE, Tuan RS. Polymerase chain reaction detection of bacterial infection in total knee arthroplasty. Clin Orthop 1996;331:11-22.
69. Tunney MM, Patrick S, Curran MD, Ramage G, Anderson N, Davis RI, Gorman SP, Nixon JR. Detection of prosthetic joint biofilm infection using immunological and molecular techniques. Methods Enzymol 1999;310:566-576.
70. Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon JR, Gorman SP, Davis RI, Anderson N. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 1999;37:3281-3290.
71. Neut D, van Horn JR, vanKooten TG, van der Mei HC, Busscher HJ. Detection of biomaterial-associated infections in orthopaedic joint implants. Clin Orthop 2003;413:261-268.
72. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg 1997;79B:590-595.
73. Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Antibiotic prophylaxis in total hip arthroplasty. Acta Orthop Scand 2003;74:644-651.
74. Chang CC, Merritt K. Infection at the site of implanted materials with and without preadhered bacteria. J Orthop Res 1994; 12:526-531.
75. van de Belt H, Neut D, Schenk W, van Horn JR, van Der Mei HC, Busscher HJ. Staphylococcus aureus biofilm formation on different gentamicin-loaded polymethylmethacrylate bone cements. Biomaterials 2001;22:1607-1611.
76. Gristina AG. Implant failure and the immuno-incompetent fibre-inflammatory zone. Clin Orthop 1994;298:106-118.
77. Nalepka JL, Greenfield EM. Detection of bacterial endotoxin in human tissues. Biotechniques 2004. Forthcoming.
78. Nalepka JL, Lee MJ, Kraay MJ, Marcus RE, Goldberg VM, Chen X, Greenfield EM. Bacterial endotoxin in aseptic loosening. 2004. Submitted.
79. Collinge CA, Goll G, Seligson D, Easley KJ. Pin tract infections: silver vs uncoated pins. Orthopaedics 1994;17:445-448.
80. Nakamoto DA, Haaga JR, Bove P, Merritt K, Rowland DY. Use of fibrinolytic agents to coat wire implants to decrease infection. Invest Radiol 1995;30:341-344.
81. An TH, Bradley J, Powers DL, Friedman RJ. The prevention of prosthetic infection using a cross-linked albumin coating in a rabbit model. J Bone Joint Surg 1997;79B:816-819.
82. Darouiche RO, Farmer J, Chaput C, Mansouri M, Saleh G, Landon GC. Anti-infective efficacy of antiseptic-coated intramedullary nails. J Bone Joint Surg 1998;80A:1336-1340.